Abstract
P402. A novel high-dose mesalazine tablet is as effective as conventional low-dose mesalazine tablets in inducing remission in patients with mildly to moderately active ulcerative colitis (UC): A double-blind, double-dummy, multicentre, randomised trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have